Für diesen Artikel ist leider kein Bild verfügbar.

Life Script (eBook)

How the Human Genome Discoveries Will Transform Medicine and Enhance Your Health
eBook Download: EPUB
2002 | 1. Auflage
208 Seiten
Simon & Schuster (Verlag)
978-0-7432-1739-2 (ISBN)
Systemvoraussetzungen
12,90 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen

With the decoding of the human genome, researchers can now read the script in which evolution has written the program for the design and operation of the human body. A new generation of medical treatments is at hand. Researchers are developing therapies so powerful that there is now no evident obstacle to the ancient goal of conquering most major diseases.

Nicholas Wade has covered the sequencing of the genome, as well as other health and science stories, for The New York Times, in the course of which he has interviewed many of the principal researchers in the field. In this book he describes what the genome means for the health of present and future generations.

Someday soon physicians will have access to DNA chips that, from a drop of blood, will screen a person's genes for all the diseases to which he or she may be genetically vulnerable. From full knowledge of the instruction manual of the human body, provided by the genome, pharmaceutical companies hope to develop a new generation of sophisticated drugs, one of the first genome-derived drugs is already undergoing clinical trials. Another vital tool will be regenerative medicine, a new kind of therapy in which new organs and tissues will be grown from a patient's own cells to replace those that are old or diseased.

With the help of DNA chips, medical researchers will soon be able to diagnose diseases such as cancer much more precisely and to tailor specific treatments for each patient. Individualized medicine will also become an important part of the pharmaceutical world. Many drugs will be prescribed based on information from DNA chips that identify which of a range of drugs is best for each patient, as well as which drugs are likely to cause side effects. The medicine of the post-genomic era will be customized for a patient's genetic make-up, providing treatments based on a precise understanding of the mechanism of disease.

Life Script describes a future in which good health, even perfect health, may become the standard for everyone -- at every age.


With the decoding of the human genome, researchers can now read the script in which evolution has written the program for the design and operation of the human body. A new generation of medical treatments is at hand. Researchers are developing therapies so powerful that there is now no evident obstacle to the ancient goal of conquering most major diseases. Nicholas Wade has covered the sequencing of the genome, as well as other health and science stories, for The New York Times, in the course of which he has interviewed many of the principal researchers in the field. In this book he describes what the genome means for the health of present and future generations. Someday soon physicians will have access to DNA chips that, from a drop of blood, will screen a person's genes for all the diseases to which he or she may be genetically vulnerable. From full knowledge of the instruction manual of the human body, provided by the genome, pharmaceutical companies hope to develop a new generation of sophisticated drugs; one of the first genome-derived drugs is already undergoing clinical trials. Another vital tool will be regenerative medicine, a new kind of therapy in which new organs and tissues will be grown from a patient's own cells to replace those that are old or diseased. With the help of DNA chips, medical researchers will soon be able to diagnose diseases such as cancer much more precisely and to tailor specific treatments for each patient. Individualized medicine will also become an important part of the pharmaceutical world. Many drugs will be prescribed based on information from DNA chips that identify which of a range of drugs is best for each patient, as well as which drugs are likely to cause side effects. The medicine of the post-genomic era will be customized for a patient's genetic make-up, providing treatments based on a precise understanding of the mechanism of disease. Life Script describes a future in which good health, even perfect health, may become the standard for everyone -- at every age.

Chapter 3: The Meaning of the Life Script

Though the two sides' claim to have sequenced the human genome sparked headlines around the world, they were celebrating victory before the battle. Each team now had to interpret its genome sequence by describing its major features and locating the genes, and from the quality of the respective reports a clear winner could emerge in the eyes of their fellow scientists.

This first analysis of the human genome was just as much a landmark in scientific history as the years spent decoding the sequence. But it was compressed into a few months' whirlwind of activity as the two sides set about interpreting the strange and enigmatic script they had wrested from the human cell. Talk of a joint annotation conference at which the two sides would compare notes in interpreting the human genome soon evaporated. Celera and the consortium worked with different groups of experts and published their reports in rival scientific journals, Celera choosing Science in Washington, D.C., and the consortium Nature in London. The sharp elbowing continued to the bitter end, with academic biologists including Eric Lander, chief author of the consortium's genome report, lobbying hard to persuade the editor of Science not to accept their rival's paper except under terms unacceptable to Celera.

The academics demanded that Celera make its genome sequence freely available through GenBank, even though GenBank could not meet Celera's condition that its commercial rivals be prevented from downloading Celera's data and reselling it. The editor of Science allowed Celera to be the custodian of its own data on condition that any part of it be made freely available to scientists for checking, a decision to which the academic biologists objected. Venter felt their real purpose was to deny him the prestige of being published in a leading academic journal.

Well before the White House announcement, both sides had started preparing to analyze their respective versions of the genome. Venter had more or less founded the art of genome interpretation when he published the first genome of a bacterium in 1995. He had learned then an important lesson: the best way of interpreting a genome is to compare it with the genome of a similar organism. He had long since decided that the mouse's genome would be a critical tool for interpreting the human genome, because comparison of the two long ago mammalian cousins would reveal by their regions of DNA sequence similarity all the features that nature had found it necessary to conserve. He had risked switching his sequencing machines from human to mouse DNA at the earliest possible moment so as to have both genomes in hand for the task of locating the human genes.

Another advantage for Celera was that its version of the human genome was much less bitty than the consortium's. Celera's vast computer, the largest in civilian use, had assembled 27 million of the 500-base pieces analyzed by the sequencing machines into long, mostly continuous scaffolds that straddled the genome. The consortium's genome was divided into thousands of the small sub-jigsaws known as BACs, chunks of DNA about 150,000 bases in length. The BACs had been completed for the two shortest human chromosomes, numbers 21 and 22, but over most of the rest of the genome were still in small pieces, many 10,000 bases or so in length. It was possible to hunt through these fragments for genes, but not at all easy. The consortium had not tried to assemble them by computer because it did not see the need to do so. Robert Waterston, director of the sequencing center at Washington University in Saint Louis, had prepared a BAC...

Erscheint lt. Verlag 2.3.2002
Sprache englisch
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie
Studium 2. Studienabschnitt (Klinik) Humangenetik
Naturwissenschaften Biologie Genetik / Molekularbiologie
Technik
ISBN-10 0-7432-1739-X / 074321739X
ISBN-13 978-0-7432-1739-2 / 9780743217392
Haben Sie eine Frage zum Produkt?
EPUBEPUB (Adobe DRM)

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich

von Berit Hackenberg; Anja Hohmann

eBook Download (2023)
Urban & Fischer Verlag - Lehrbücher
26,99
Leber, Gallenwege und Pankreas

von Andrea Tannapfel; Günter Klöppel

eBook Download (2020)
Springer Berlin Heidelberg (Verlag)
299,00